Proteomic technologies for prenatal diagnostics: advances and challenges ahead

被引:34
作者
Choolani, Mahesh [1 ]
Narasimhan, Kothandaraman [1 ]
Kolla, Varaprasad [1 ]
Hahn, Sinuhe [2 ]
机构
[1] Natl Univ Singapore Hosp, Diagnost Biomarker Discovery Lab, Dept Obstet & Gynaecol, Singapore 119074, Singapore
[2] Univ Womens Hosp, Dept Biomed, Lab Prenatal Med, CH-4031 Basel, Switzerland
关键词
amniotic fluid; biomarker; chromosomal aneuploidies fetal abnormalities; mass spectrometry; noninvasive prenatal diagnosis; prenatal diagnosis; proteomics; HUMAN AMNIOTIC-FLUID; MATERNAL SERUM; PREMATURE RUPTURE; ALPHA-FETOPROTEIN; EXPRESSION ANALYSIS; PROTEIN EXPRESSION; MASS-SPECTROMETRY; FETAL ANEUPLOIDY; PEPTIDE PATTERNS; EARLY-PREGNANCY;
D O I
10.1586/14789450.6.1.87
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Proteomics-based identification of biomarkers for fetal abnormalities in maternal plasma, amniotic fluid and reproductive fluids has made significant progress in the past 5 years. This is attributed mainly to advances in various technology platforms associated with mass spectrometry-based techniques. As these techniques are highly sensitive and require only small quantities of body fluids, it is hoped that they will pave the way for the development of effective noninvasive approaches, without subjecting the developing fetus to the same degree of harm as current invasive procedures (e.g., amniocentesis). It is possible that these developments will include same-day analyses, thereby permitting rapid intervention when necessary. To date, a host of body fluids, such as maternal serum and plasma, amniotic fluid, cervical fluid, vaginal fluid, urine, saliva or fetal material, such as placental trophoblast, fetal membranes or cord blood, have been used successfully in the quest to develop markers for a number of pregnancy-related pathologies, in the current review update we focus on the emergence of proteomics as a major platform technology in studying various types of fetal conditions and developing markers for pregnancy-related disorders, such fetal aneuploidy, preterm birth, preeclampsia, intra-amniotic infection and fetal stress. Should the development of these markers be successful, then it is to be envisaged that proteomic approaches will become standard of care for a number of disease conditions associated with feto-maternal health.
引用
收藏
页码:87 / 101
页数:15
相关论文
共 106 条
  • [91] Proteomic analysis of proteins differentially expressed in preeclamptic trophoblasts
    Sun, Li-zhou
    Yang, Na-na
    De, Wei
    Xiao, Yun-shan
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2007, 64 (01) : 17 - 23
  • [92] The role of proteomics in the assessment of premature rupture of fetal membranes
    Thadikkaran, L
    Crettaz, D
    Siegenthaler, MA
    Gallot, D
    Sapin, V
    Iozzo, RV
    Queloz, PA
    Schneider, P
    Tissot, JD
    [J]. CLINICA CHIMICA ACTA, 2005, 360 (1-2) : 27 - 36
  • [93] Angiogenic factors and preeclampsia
    Tjoa, May Lee
    Levine, Richard J.
    Karumanchi, S. Ananth
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 2395 - 2402
  • [94] The amniotic fluid cell proteome
    Tsangaris, G
    Weitzdörfer, R
    Pollak, D
    Lubec, G
    Fountoulakis, M
    [J]. ELECTROPHORESIS, 2005, 26 (06) : 1168 - 1173
  • [95] Tsangaris GT, 2006, IN VIVO, V20, P479
  • [96] Proteomic analysis of amniotic fluid in pregnancies with Down syndrome
    Tsangaris, George Th.
    Karamessinis, Panagiotis
    Kolialexi, Aggeliki
    Garbis, Spiros D.
    Antsaklis, Aris
    Mavrou, Ariadni
    Fountoulakis, Michael
    [J]. PROTEOMICS, 2006, 6 (15) : 4410 - 4419
  • [97] Inhibins as diagnostic markers in human reproduction
    Tsigkou, Anastasia
    Luisi, Stefano
    Reis, Fernando M.
    Petraglia, Felice
    [J]. ADVANCES IN CLINICAL CHEMISTRY, VOL 45, 2008, 45 : 1 - 29
  • [98] Amniotic fluid: Not just fetal urine anymore
    Underwood M.A.
    Gilbert W.M.
    Sherman M.P.
    [J]. Journal of Perinatology, 2005, 25 (5) : 341 - 348
  • [99] Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia
    Vascotto, Carlo
    Salzano, Anna Maria
    D'Ambrosio, Chiara
    Fruscalzo, Arrigo
    Marchesoni, Diego
    di Loreto, Carla
    Scaloni, Andrea
    Tell, Gianluca
    Quadrifoglio, Franco
    [J]. JOURNAL OF PROTEOME RESEARCH, 2007, 6 (01) : 160 - 170
  • [100] Identification of biologic markers of the premature rupture of fetal membranes:: Proteomic approach
    Vuadens, F
    Benay, C
    Crettaz, D
    Gallot, D
    Sapin, V
    Schneider, P
    Bienvenut, WV
    Lémery, D
    Quadroni, M
    Dastugue, B
    Tissot, JD
    [J]. PROTEOMICS, 2003, 3 (08) : 1521 - 1525